Skip to main content
logo
Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
3.310
-0.300 (-8.31%)
At close: Oct 30, 2026, 4:00 PM EDT
3.396
+0.086 (2.60%)
After-hours: Oct 30, 2026, 7:30 PM EDT

Psyence Biomedical Financials Overview

Millions USD. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Income
-6.24-6.24-3.66-2.75-3.23-1.86
Net Income
-6.94-6.941.01-51.16-3.21-1.86
Earnings Per Share
-12.56-12.5632.76---
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
7.447.446.140.731.331.76
Total Debt
---10.45--
Net Cash (Debt)
7.447.446.14-9.711.331.76
Net Cash Growth
21.35%21.35%---23.97%-
Net Cash Per Share
13.4813.48198.63---

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-8.14-8.14-3.73-2.95-1.59-1.4
Capital Expenditures
-0-0-0.01-0.01--
Free Cash Flow
-8.14-8.14-3.74-2.95-1.59-1.4
Free Cash Flow Growth
------

Valuation
Chart
Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
--2.69---